Looks like the 2 new patents are cancer treatment related: The anti-CD38 antibody patent is a cancer therapy. ie multiple myeloma. That, along with the disulfide conjugation, it appears they are looking to conjugate a chemotherapy to the anti-CD38 as a cancer treatment.